Lindbrook Capital’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
RP
BTW
Lindbrook Capital's ACLS Position: Q1 2025 in Review
Lindbrook Capital increased its Axcelis (ACLS) stake by 364% in Q1 2025, buying an estimated $15.2K and bringing the position to 306 shares worth $15.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1471.
Lindbrook Capital first reported a position in ACLS in Q3 2022 and has held it in 11 quarters since. 306 funds tracked by Wall St. Rank hold ACLS as of Q1 2025.
- Lindbrook Capital held 306 shares of Axcelis worth $15.2K as of Q1 2025.
- Lindbrook Capital bought 240 Axcelis shares in Q1 2025, an estimated $15.2K.
- Axcelis made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #1471 holding.
- Lindbrook Capital first reported a position in Axcelis in Q3 2022 and has held it in 11 quarters since.
- 306 funds tracked by Wall St. Rank held Axcelis as of Q1 2025.
Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.